CM
AXSM icon

Caption Management’s Axsome Therapeutics AXSM Stock Holding History

Caption Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-115,686
Closed -$13.2M – 1512
2024
Q4 		$9.79M Buy
115,686
+105,686
+1,057% +$9.72M 0.09% 205
2024
Q3 		$899K Buy
+10,000
New +$873K 0.01% 805
2024
Q1 		– Sell
-17,600
Closed -$1.48M – 1202
2023
Q4 		$1.4M Buy
+17,600
New +$1.18M 0.02% 721
2023
Q1 		– Sell
-4,600
Closed -$302K – 1087
2022
Q4 		$355K Buy
+4,600
New +$275K 0.01% 981
2022
Q2 		– Sell
-157,500
Closed -$4.98M – 1447
2022
Q1 		$6.52M Buy
157,500
+117,500
+294% +$3.64M 0.08% 344
2021
Q4 		$1.51M Sell
40,000
-29,000
-42% -$1.07M 0.02% 890
2021
Q3 		$2.27M Buy
+69,000
New +$2.69M 0.03% 716
2020
Q2 		– Sell
-25,000
Closed -$1.47M – 927
2020
Q1 		$1.47M Sell
25,000
-63,400
-72% -$5.17M 0.08% 322
2019
Q4 		$9.14M Buy
+88,400
New +$3.57M 0.31% 74
2019
Q2 		– Sell
-30,000
Closed -$601K – 654
2019
Q1 		$427K Buy
+30,000
New +$279K 0.02% 447

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caption Management's AXSM Position: Q1 2025 in Review

Caption Management sold out of Axsome Therapeutics (AXSM) in Q1 2025, closing a stake of 115,686 shares — an estimated $13.2M sold.

Caption Management first reported a position in AXSM in Q1 2019 and held it in 10 quarters. The position peaked at $9.79M in Q4 2024. 353 funds tracked by Wall St. Rank hold AXSM as of Q1 2025.

  • Caption Management reported no remaining Axsome Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Caption Management sold 115,686 Axsome Therapeutics shares in Q1 2025, an estimated $13.2M.
  • Caption Management first reported a position in Axsome Therapeutics in Q1 2019 and held it in 10 quarters.
  • Caption Management's Axsome Therapeutics position peaked at $9.79M in Q4 2024.
  • 353 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.